You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

REVIEW article

Front. Cell Dev. Biol.

Sec. Molecular and Cellular Reproduction

The Role of the Reproductive Tract and Follicular Fluid Microbiota in IVF/ICSI Pregnancy Outcomes: A Systematic Review of Microbial Diversity and Probiotic Interventions

  • Reproductive Centre, Department of Obstetrics and Gynaecology, West China Second University Hospital, Sichuan University, Chengdu, 610041, China

Article metrics

View details

149

Views

The final, formatted version of the article will be published soon.

Abstract

Objective: To investigate associations between reproductive tract and follicular fluid microbiota composition, microbial diversity, and probiotic interventions with pregnancy outcomes after in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI). Data sources: PubMed, Embase, Web of Science, and the Cochrane Library were searched from January 2000 to August 2025, with manual screening of references. Study eligibility criteria: Original human studies on women undergoing IVF/ICSI reporting reproductive tract or follicular fluid microbiota, pregnancy outcomes, or probiotic interventions. Included designs comprised randomized controlled trials and observational studies. Study appraisal and synthesis methods: Two reviewers independently screened, extracted, and assessed study quality using RoB 2.0, ROBINS-I, and JBI tools. Due to heterogeneity in study designs, sampling sites, and microbiota methods, we performed a qualitative synthesis. Results: Of 2546 records, 40 studies were finally included. Most studies reported that a Lactobacillus-dominant reproductive tract microbiota, particularly Lactobacillus crispatus, was associated with higher implantation, clinical pregnancy, and live birth rates, whereas non-Lactobacillus or pathogen-enriched profiles correlated with poorer outcomes. Microbial diversity alone was inconsistently predictive. Evidence for follicular fluid microbiota influencing pregnancy outcomes was limited. Longer-term or individualized probiotic regimens increased Lactobacillus abundance and were linked to improved outcomes, while short-term interventions showed minimal effect. Conclusion: Species-level and site-specific reproductive tract microbiota better predict assisted reproductive technology outcomes than diversity measures alone. Personalized or longer-duration probiotic strategies may be beneficial, but current evidence is limited and heterogeneous. Well-designed longitudinal, site-specific trials are needed to determine the efficacy of microbiota-targeted interventions in IVF/ICSI.

Summary

Keywords

Follicular Fluid, in vitro fertilization, Intracytoplasmic sperm injection, pregnancy outcomes, Probiotics, reproductive tract microbiota

Received

02 December 2025

Accepted

05 February 2026

Copyright

© 2026 Ma, Peng, Cai, He, Han, Gao and Qin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Rui Gao; Lang Qin

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Share article

Article metrics